Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Myocardial Fibrosis Improves in Young Patients with Sickle Cell Disease after Hematopoietic Cell Transplantation

Akshay Sharma, Anthony Merlocco, Cara Morin, Subodh Selukar, Yu Bi, Chris Goode, Parul Rai, Brandon M Triplett, Jeffrey Towbin, Jane S Hankins, Jason N Johnson

Blood (2023) 142 (Supplement 1): 2518.

https://doi.org/10.1182/blood-2023-178267

Published: 2023

Journal Articles

Cerebral Oxygen Metabolism Improves Following Hematopoietic Cell Transplantation in Children with Sickle Cell Disease

Chih-Chiang Chang, Matthew A. Scoggins, Ping Zou, Sydney Somogyi, Soniya Pinto, Kathleen Helton, Jane S Hankins, Brandon M Triplett, Akshay Sharma, Ranganatha Sitaram

Blood (2023) 142 (Supplement 1): 2519.

https://doi.org/10.1182/blood-2023-179363

Published: 2023

Journal Articles

Allogeneic Hematopoietic Cell Transplantation for Acute Megakaryocytic Leukemia: A Single Center Study

Shruthi Suryaprakash, Yu Bi, Subodh Selukar, Dinesh Keerthi, Amr Qudeimat, Aimee C. Talleur, Ewelina K. Mamcarz, Ashok Srinivasan, Madden Renee, Rebecca Epperly, Swati Naik, Stephen Gottschalk, Brandon M Triplett, Akshay Sharma

Blood (2023) 142 (Supplement 1): 7087.

https://doi.org/10.1182/blood-2023-179853

Published: 2023

Journal Articles

Risk-Adapted Donor Lymphocyte Infusion after Hematopoietic Cell Transplant in Pediatric and Young Adult Patients Is Associated with Low Risk of Graft Versus Host Disease

Shruthi Suryaprakash, Yilun Sun, Li Tang, Dinesh Keerthi, Amr Qudeimat, Aimee C. Talleur, Ewelina K. Mamcarz, Ashok Srinivasan, Madden Renee, Rebecca Epperly, Swati Naik, Stephen Gottschalk, Brandon M Triplett, Akshay Sharma

Blood (2023) 142 (Supplement 1): 7042.

https://doi.org/10.1182/blood-2023-182639

Published: 2023

Journal Articles

Safety and Anti-Leukemic Activity of CD123-CAR T Cells in Pediatric Patients with AML: Preliminary Results from a Phase 1 Trial

Blood (2022) 140 (Supplement 1): 4584–4585.

https://doi.org/10.1182/blood-2022-170201

Published: 2022

Journal Articles

CD45RA-Depleted Haploidentical Transplantation Combined with NK Cell Addback Results in Promising Long-Term Outcomes in Pediatric Patients with High-Risk Hematologic Malignancies

Swati Naik, Aimee C Talleur, Ying Li, Renee M. Madden, Ewelina Mamcarz, Amr Qudeimat, Akshay Sharma, Ashok Srinivasan, Ali Y Suliman, Rebecca Epperly, Esther A. Obeng, Mireya Paulina Velasquez, Diego Hijano, Gabriela Maron, Stephen Gottschalk, Brandon M Triplett

Blood (2021) 138 (Supplement 1): 172.

https://doi.org/10.1182/blood-2021-149655

Published: 2021

Journal Articles

Liposome-Encapsulated Cytarabine and Daunorubicin (CPX-351) Induces Remission in Newly Diagnosed Pediatric Secondary Myeloid Malignancies

Kenneth J Caldwell, Yixin Hu, Mihaela Onciu, Sara M Federico, Marta Salek, Sara Lewis, Shaohua Lei, Jinghui Zhang, Kim E. Nichols, Clifford M Takemoto, Brandon M Triplett, Jason E Farrar, Jeffrey E. Rubnitz, Raul C Ribeiro, Marcin W. Wlodarski

Blood (2021) 138 (Supplement 1): 4415.

https://doi.org/10.1182/blood-2021-149619

Published: 2021

Journal Articles

CD19-CAR T Cells Develop Exhaustion Epigenetic Programs during a Clinical Response

Caitlin C. Zebley, Charmaine Brown, Tian Mi, Yiping Fan, Shanta Alli, Shannon Boi, Giovanni Galletti, Enrico Lugli, Deanna Langfitt, Jean-Yves Metais, Timothy Lockey, Michael M Meagher, Brandon M Triplett, Aimee C Talleur, Stephen Gottschalk, Benjamin Youngblood

Blood (2021) 138 (Supplement 1): 2782.

https://doi.org/10.1182/blood-2021-151177

Published: 2021

Journal Articles

CD45RO+ T-Cell Add Back and Prophylactic Blinatumomab Administration Post Tcrαβ/CD19-Depleted Haploidentical Transplantation in Pediatric Patients with High Risk Acute Leukemia

Swati Naik, Renee M. Madden, Ewelina Mamcarz, Ashok Srinivasan, Akshay Sharma, Aimee C Talleur, Rebecca Epperly, Amr Qudeimat, Ali Y Suliman, Esther A. Obeng, Mireya Paulina Velasquez, Diego Hijano, Gabriela Maron, Ying Li, Stephen Gottschalk, Brandon M Triplett

Blood (2021) 138 (Supplement 1): 2897.

https://doi.org/10.1182/blood-2021-149671

Published: 2021

Journal Articles

Assessment of Cardiac Abnormalities in Sickle Cell Disease Patients Using Cardiac Magnetic Resonance Imaging (CMR)

Cara Morin, Akshay Sharma, Gary Beasley, Jane S Hankins, Stacy High, Amanda Kennedy, Richard Lovins, Parul Rai, Brandon M Triplett, Jason Johnson

Blood (2021) 138 (Supplement 1): 3110.

https://doi.org/10.1182/blood-2021-149227

Published: 2021

Journal Articles

Reduced Intensity Hematopoietic Cell Transplantation Improves Cerebral Hemodynamics in Children with Sickle Cell Disease

Akshay Sharma, Matthew Scoggins, Ping Zou, Amanda Kennedy, Richard Lovins, Sanjay Verma, Stacy High, Ranganatha Sitaram, Brandon M Triplett, Jane S Hankins, Zoltan Patay

Blood (2021) 138 (Supplement 1): 125.

https://doi.org/10.1182/blood-2021-144993

Published: 2021

Journal Articles

Allogeneic Hematopoietic Cell Transplantation Is Critical to Maintain Remissions after CD19-CAR T-Cell Therapy for Pediatric ALL: A Single Center Experience

Blood (2020) 136 (Supplement 1): 39–40.

https://doi.org/10.1182/blood-2020-138528

Published: 2020

Journal Articles

Impact on Outcomes of Baseline Bilirubin in Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Receiving Defibrotide Treatment: A Post-Hoc Analysis

Paul G. Richardson, MD, Angela R. Smith, MD, Brandon M. Triplett, MD, Nancy A. Kernan, MD, Stephan A. Grupp, MD PhD, Joseph H. Antin, MD, Leslie Lehmann, MD, Wei Liang, PhD, Robin Hume, MS, William Tappe, MD, Robert J. Soiffer, MD

Blood (2016) 128 (22): 2213.

https://doi.org/10.1182/blood.V128.22.2213.2213

Published: 2016

Journal Articles

Timing of Initiation of Defibrotide Post-Diagnosis of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Post-Hematopoietic Stem Cell Transplantation: Exploratory Age-Group Analysis from an Expanded Access Study

Stephan A. Grupp, MD PhD, Angela R. Smith, MD, Brandon M. Triplett, MD, Nancy A. Kernan, MD, Joseph H. Antin, MD, Leslie Lehmann, MD, Wei Liang, PhD, Robin Hume, MS, William Tappe, MD, Paul G. Richardson, MD

Blood (2016) 128 (22): 66.

https://doi.org/10.1182/blood.V128.22.66.66

Published: 2016

Journal Articles

Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) Post-Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Acute Leukemias: A Subgroup Analysis from the Defibrotide Expanded-Access Program

Blood (2016) 128 (22): 3412.

https://doi.org/10.1182/blood.V128.22.3412.3412

Published: 2016

Journal Articles

Reduction in CMV and Adenovirus Viremia after Haploidentical Donor Transplantation Utilizing CD45RA Depletion and NK Cell Infusion

Brandon M. Triplett, MD, Bradley Muller, Guolian Kang, PhD, Shane J Cross, PharmD, Joseph Moen, Mari H Dallas, MD, Christine Hartford, MD, William E. Janssen, PhD, Ping Law, PhD, Ewelina K. Mamcarz, MD, David R Shook, MD, Ashok Srinivasan, MD, Randall T Hayden, MD, Wing Leung, MD PhD

Blood (2015) 126 (23): 624.

https://doi.org/10.1182/blood.V126.23.624.624

Published: 2015

Journal Articles

Early Initiation of Defibrotide in Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Following Hematopoietic Stem Cell Transplantation Improves Day +100 Survival

Paul G. Richardson, MD, Angela R. Smith, MD MS, Brandon M. Triplett, MD, Nancy A. Kernan, MD, Stephan A. Grupp, MD PhD, Joseph H. Antin, MD, Leslie E. Lehmann, MD, Maja Miloslavsky, PhD, Robin L. Hume, MS, Alison L. Hannah, MD, Bijan Nejadnik, MD, Robert J. Soiffer, MD

Blood (2015) 126 (23): 4311.

https://doi.org/10.1182/blood.V126.23.4311.4311

Published: 2015

Journal Articles

Defibrotide for the Treatment of Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome with/without Multi-Organ Dysfunction Following Chemotherapy: Results from an Ongoing Expanded Access Program

Nancy A. Kernan, MD, Paul G. Richardson, MD, Angela R. Smith, MD, Brandon M. Triplett, MD, Stephan A. Grupp, MD PhD, Joseph H. Antin, MD, Leslie E. Lehmann, MD, Wei Liang, PhD, Robin L. Hume, MS, Alison L. Hannah, MD, Bijan Nejadnik, MD, Robert J. Soiffer, MD

Blood (2015) 126 (23): 3121.

https://doi.org/10.1182/blood.V126.23.3121.3121

Published: 2015

Journal Articles

Updated Results from a Large, Ongoing, Treatment IND Study Using Defibrotide for Patients with Hepatic Veno-Occlusive Disease

Paul G. Richardson, Angela R. Smith, MD MS, Brandon M. Triplett, MD, Nancy A. Kernan, MD, Stephan A. Grupp, MD PhD, Sally Arai, MD, Joseph H. Antin, MD, Leslie E. Lehmann, MD, Valeria Bandiera, Robin L. Hume, MS, Alison L. Hannah, MD, Bijan Nejadnik, MD, Robert J. Soiffer, MD, Defibrotide Study Group

Blood (2014) 124 (21): 2470.

https://doi.org/10.1182/blood.V124.21.2470.2470

Published: 2014

Journal Articles

Transplant Outcome of Pediatric and Young Adult Patients with Aplastic Anemia: St Jude Children’s Research Hospital Experience

Hesham Eissa, MD, Brandon M. Triplett, MD, Mari H Dallas, MD, Ashok Srinivasan, MD, Christine Hartford, MD, Ulrike M. Reiss, MD, Winfred C. Wang, MD, Wing Leung, MD PhD

Blood (2014) 124 (21): 1210.

https://doi.org/10.1182/blood.V124.21.1210.1210

Published: 2014

NARROW

Myocardial Fibrosis Improves in Young Patients with Sickle Cell Disease after Hematopoietic Cell Transplantation

Cerebral Oxygen Metabolism Improves Following Hematopoietic Cell Transplantation in Children with Sickle Cell Disease

Allogeneic Hematopoietic Cell Transplantation for Acute Megakaryocytic Leukemia: A Single Center Study

Risk-Adapted Donor Lymphocyte Infusion after Hematopoietic Cell Transplant in Pediatric and Young Adult Patients Is Associated with Low Risk of Graft Versus Host Disease

Safety and Anti-Leukemic Activity of CD123-CAR T Cells in Pediatric Patients with AML: Preliminary Results from a Phase 1 Trial

CD45RA-Depleted Haploidentical Transplantation Combined with NK Cell Addback Results in Promising Long-Term Outcomes in Pediatric Patients with High-Risk Hematologic Malignancies

Liposome-Encapsulated Cytarabine and Daunorubicin (CPX-351) Induces Remission in Newly Diagnosed Pediatric Secondary Myeloid Malignancies

CD19-CAR T Cells Develop Exhaustion Epigenetic Programs during a Clinical Response

CD45RO+ T-Cell Add Back and Prophylactic Blinatumomab Administration Post Tcrαβ/CD19-Depleted Haploidentical Transplantation in Pediatric Patients with High Risk Acute Leukemia

Assessment of Cardiac Abnormalities in Sickle Cell Disease Patients Using Cardiac Magnetic Resonance Imaging (CMR)

Reduced Intensity Hematopoietic Cell Transplantation Improves Cerebral Hemodynamics in Children with Sickle Cell Disease

Allogeneic Hematopoietic Cell Transplantation Is Critical to Maintain Remissions after CD19-CAR T-Cell Therapy for Pediatric ALL: A Single Center Experience

Impact on Outcomes of Baseline Bilirubin in Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Receiving Defibrotide Treatment: A Post-Hoc Analysis

Timing of Initiation of Defibrotide Post-Diagnosis of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Post-Hematopoietic Stem Cell Transplantation: Exploratory Age-Group Analysis from an Expanded Access Study

Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) Post-Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Acute Leukemias: A Subgroup Analysis from the Defibrotide Expanded-Access Program

Reduction in CMV and Adenovirus Viremia after Haploidentical Donor Transplantation Utilizing CD45RA Depletion and NK Cell Infusion

Early Initiation of Defibrotide in Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Following Hematopoietic Stem Cell Transplantation Improves Day +100 Survival

Defibrotide for the Treatment of Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome with/without Multi-Organ Dysfunction Following Chemotherapy: Results from an Ongoing Expanded Access Program

Updated Results from a Large, Ongoing, Treatment IND Study Using Defibrotide for Patients with Hepatic Veno-Occlusive Disease

Transplant Outcome of Pediatric and Young Adult Patients with Aplastic Anemia: St Jude Children’s Research Hospital Experience

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only